Literature DB >> 9829917

Structural and functional characterization of IS1358 from Vibrio cholerae.

S Dumontier1, P Trieu-Cuot, P Berche.   

Abstract

The new epidemic serovar O139 of Vibrio cholerae has emerged from the pandemic serovar O1 biotype El Tor through the replacement of a 22-kbp DNA region by a 40-kbp O139-specific DNA fragment. This O139-specific DNA fragment contains an insertion sequence that was described previously (U. H. Stroeher, K. E. Jedani, B. K. Dredge, R. Morona, M. H. Brown, L. E. Karageorgos, J. M. Albert, and P. A. Manning, Proc. Natl. Acad. Sci. USA 92:10374-10378, 1995) and designated IS1358O139. We studied the distribution of the IS1358 element in strains from various serovars by Southern analysis. Its presence was detected in strains from serovars O1, O2, O22, O139, and O155 but not in strains from serovars O15, O39, and O141. Furthermore, IS1358 was present in multiple copies in strains from serovars O2, O22, and O155. We cloned and sequenced four copies of IS1358 from V. cholerae O22 and one copy from V. cholerae O155. A comparison of their nucleotide sequences with those of O1 and O139 showed that they were almost identical. We constructed a transposon consisting of a kanamycin resistance gene flanked by two directly oriented copies of IS1358 to study the functionality of this element. Transposition of this element from a nonmobilizable plasmid onto the conjugative plasmid pOX38-Gen was detected in an Escherichia coli recA donor at a frequency of 1.2 x 10(-8). Sequence analysis revealed that IS1358 duplicates 10 bp at its insertion site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829917      PMCID: PMC107693          DOI: 10.1128/JB.180.23.6101-6106.1998

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  39 in total

1.  The rfaD locus: a region of rearrangement in Vibrio cholerae O139.

Authors:  S Vimont; S Dumontier; V Escuyer; P Berche
Journal:  Gene       Date:  1997-01-31       Impact factor: 3.688

2.  A distinctive class of integron in the Vibrio cholerae genome.

Authors:  D Mazel; B Dychinco; V A Webb; J Davies
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

3.  Structural analysis of the lipopolysaccharide from Vibrio cholerae serotype O22.

Authors:  A D Cox; J R Brisson; P Thibault; M B Perry
Journal:  Carbohydr Res       Date:  1997-11-28       Impact factor: 2.104

4.  Vibrio cholerae serotype O139: swapping genes for surface polysaccharide biosynthesis.

Authors:  U H Stroeher; P A Manning
Journal:  Trends Microbiol       Date:  1997-05       Impact factor: 17.079

Review 5.  The evolution of epidemic Vibrio cholerae strains.

Authors:  F R Mooi; E M Bik
Journal:  Trends Microbiol       Date:  1997-04       Impact factor: 17.079

6.  Identification of a second endogenous Porphyromonas gingivalis insertion element.

Authors:  C Y Wang; V C Bond; C A Genco
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

7.  Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis.

Authors:  U H Stroeher; G Parasivam; B K Dredge; P A Manning
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

8.  Structural analysis of the lipopolysaccharide from Vibrio cholerae O139.

Authors:  A D Cox; J R Brisson; V Varma; M B Perry
Journal:  Carbohydr Res       Date:  1996-08-26       Impact factor: 2.104

9.  Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1.

Authors:  L E Comstock; J A Johnson; J M Michalski; J G Morris; J B Kaper
Journal:  Mol Microbiol       Date:  1996-02       Impact factor: 3.501

10.  Genetic organization and functional analysis of the otn DNA essential for cell-wall polysaccharide synthesis in Vibrio cholerae O139.

Authors:  E M Bik; A E Bunschoten; R J Willems; A C Chang; F R Mooi
Journal:  Mol Microbiol       Date:  1996-05       Impact factor: 3.501

View more
  8 in total

1.  Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups.

Authors:  S Sozhamannan; Y K Deng; M Li; A Sulakvelidze; J B Kaper; J A Johnson; G B Nair; J G Morris
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Evidence for the horizontal transfer of an unusual capsular polysaccharide biosynthesis locus in marine bacteria.

Authors:  Alina Nakhamchik; Caroline Wilde; Henry Chong; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

3.  Acquisition of the rfb-gnd cluster in evolution of Escherichia coli O55 and O157.

Authors:  P I Tarr; L M Schoening; Y L Yea; T R Ward; S Jelacic; T S Whittam
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

4.  Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain.

Authors:  T A Hoover; D W Culp; M H Vodkin; J C Williams; H A Thompson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  NhaA, an Na(+)/H(+) antiporter involved in environmental survival of Vibrio cholerae.

Authors:  S Vimont; P Berche
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

6.  Characterization of vibrio cholerae O1 antigen as the bacteriophage K139 receptor and identification of IS1004 insertions aborting O1 antigen biosynthesis.

Authors:  J Nesper; D Kapfhammer; K E Klose; H Merkert; J Reidl
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

7.  Identification of genetic loci required for capsular expression in Vibrio vulnificus.

Authors:  Amy B Smith; Ronald J Siebeling
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Identification of a Wzy polymerase required for group IV capsular polysaccharide and lipopolysaccharide biosynthesis in Vibrio vulnificus.

Authors:  Alina Nakhamchik; Caroline Wilde; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.